AT77317B - Process for the preparation of mercury solutions suitable for injection. - Google Patents
Process for the preparation of mercury solutions suitable for injection.Info
- Publication number
- AT77317B AT77317B AT77317DA AT77317B AT 77317 B AT77317 B AT 77317B AT 77317D A AT77317D A AT 77317DA AT 77317 B AT77317 B AT 77317B
- Authority
- AT
- Austria
- Prior art keywords
- mercury
- injection
- preparation
- succinimide
- solutions suitable
- Prior art date
Links
- 239000000243 solution Substances 0.000 title description 8
- 238000002347 injection Methods 0.000 title description 6
- 239000007924 injection Substances 0.000 title description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 title description 6
- 229910052753 mercury Inorganic materials 0.000 title description 6
- 238000002360 preparation method Methods 0.000 title description 3
- 238000000034 method Methods 0.000 title description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 13
- 229960002317 succinimide Drugs 0.000 description 6
- 229940100892 mercury compound Drugs 0.000 description 4
- 150000002731 mercury compounds Chemical class 0.000 description 4
- UXSFLUAWGUTZMP-UHFFFAOYSA-N mercury;pyrrolidine-2,5-dione Chemical compound [Hg].O=C1CCC(=O)N1 UXSFLUAWGUTZMP-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010024769 Local reaction Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- -1 sulfophenol carboxylic acids Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
<Desc/Clms Page number 1>
Verfahren zur Herstellung von zu Injektionszwecken geeigneten Quecksilberlösungen.
EMI1.1
wart von Alkalien wasserlöslich. Der komplexen Alkalisalzlösung haftet jedoch hinwieder der Übelstand an, dass die Gegenwart des Alkalis bei der Einspritzung schmerzhaft wirkt, so dass diese nicht ohne Anwendung von anesthätischen Mitteln erfolgen kann, wobei trotzdem starke örtliche Reaktionen auftreten.
Wir haben nun gefunden, dass sich nicht nur die Quecksilberverbindung der Sulfe- salizylsäure, sondern auch anderer Sulfophenolkarbonsäuren oder Phenoisutfosäuren oder aber deren Halogensustitutionsprodukte, in Gegenwart von Succinimid in Wasser lösen und zwar ohne dass das Quecksilbersalz des Succinimides gebildet wird.
Succinimidquecksilber wurde schon für Injektionszwecke vorgeschlagen; obzwar diese Präparat bei der Injektion keine lokale Reaktion verursacht, hatte sich das Succinimidquecksilber wegen seiner leichten Zersetzlichkeit nicht eingeführt.
Aus den in Gegenwart von Succinimid hergestellten Lösungen lassen sich durch verdünnte Säuren wieder die ursprünglichen, schwer löslichen Quecksilberverbindungen ausfällen, woraus hervorgeht, dass das Quecksilber nicht als Succinimidquecksilber zugegen sein kann.
Da die in Gegenwart von Succinimid unter Vermeidung von Alkalien hergestellten
Lösungen der eingangs erwähnten Quecksilberverbindungen beim Einspritzen weder
Schmerzen noch örtlichen Reaktionen verursachen, äusserst beständig sind und das Queck- silber in maskierter Bindung enthalten, so eignen sie sich ganz hervorragend für Injektions- zwecke@
EMI1.2
sich auch in Gegenwart von Succinimid nicht in Wasser mit Ausnahme des einfachen Phenotquecksitbers, das jedoch unter Bildung von gewöhnlichem Succinimidquecksilbar in Lösung geht, was gemäss der Erfindung gerade vermieden werden soll und durch die abweichende Konstruktion des Phenolquecksilbera erklärlich ist linen übergang bildet das maskierte Qecksilbersalz des l'hlorpheno18, welches sich, wenn auch schwer in Succinimid lÖst,
doch ist die Lösung unbeständig und kommt demnach für den angestrebten Zweck nicht in Betracht.
EMI1.3
paraphenolsultosaures Natrium wird mit dem ein- bis zweifachen des molekulären Gewichtes Quecksilheracetat in Wasserlösung gekocht, wobei sich eine bisher nicht beschriebene, schwer lösliche dem sulfosalizylsauren Quecksilber entsprechende Quecksilber- Verbindung ausscheidet.
Der von uof Lösung getrennte und gewaschene Niederschlag wird in 10 bis 15 Ge-
EMI1.4
angegeben, weiter behandelt.
Die ive avenge des Wassers und Succinimides kann je nach den Bedürfnissen geändert werden.
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
Process for the preparation of mercury solutions suitable for injection.
EMI1.1
were water-soluble from alkalis. The complex alkali salt solution, however, has the disadvantage that the presence of the alkali during the injection is painful, so that this cannot take place without the use of anesthetic agents, whereby strong local reactions nevertheless occur.
We have now found that not only the mercury compound of sulfosalicylic acid, but also other sulfophenol carboxylic acids or phenoisutfoic acids or their halogen substitution products, dissolve in water in the presence of succinimide and without the mercury salt of succinimide being formed.
Succinimide mercury has been suggested for injection purposes; Although this preparation caused no local reaction when injected, succinimide mercury was not introduced because of its easy decomposition.
The original, sparingly soluble mercury compounds can be precipitated again from the solutions prepared in the presence of succinimide by dilute acids, from which it can be seen that the mercury cannot be present as succinimide mercury.
Since those produced in the presence of succinimide avoiding alkalis
Solutions of the mercury compounds mentioned at the beginning neither during injection
Pain still cause local reactions, are extremely persistent and contain the mercury in masked bond, they are ideal for injection purposes @
EMI1.2
not even in the presence of succinimide in water with the exception of the simple phenolic mercury, which, however, goes into solution with the formation of ordinary succinimide mercury, which according to the invention is to be avoided and can be explained by the different construction of the phenolic mercury l'hlorpheno18, which, although difficult to dissolve in succinimide,
but the solution is inconsistent and therefore cannot be considered for the intended purpose.
EMI1.3
Sodium paraphenol is boiled in water solution with one to two times the molecular weight of mercury acetate, whereby a previously not described, sparingly soluble mercury compound corresponding to the sulphosalicylic acid is precipitated.
The precipitate, separated from the solution and washed, is poured into 10 to 15
EMI1.4
specified, treated further.
The ive avenge of the water and succinimides can be changed according to the needs.
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT77317T | 1917-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT77317B true AT77317B (en) | 1919-07-25 |
Family
ID=3598925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT77317D AT77317B (en) | 1917-03-26 | 1917-03-26 | Process for the preparation of mercury solutions suitable for injection. |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT77317B (en) |
-
1917
- 1917-03-26 AT AT77317D patent/AT77317B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT77317B (en) | Process for the preparation of mercury solutions suitable for injection. | |
| DE453808C (en) | Disinfectants | |
| AT112734B (en) | Process for the preparation of monocamphorates of the Solanaceae alkaloids. | |
| AT138022B (en) | Process for the preparation of hexamethylene hexamine hexajodide. | |
| AT129764B (en) | Process for the preparation of new water-soluble compounds of 2-phenylquinoline-4-carboxylic acid and its derivatives. | |
| AT107595B (en) | Process for the preparation of 2-amino-3-nitropyridine-5-sulfonic acid. | |
| AT97145B (en) | Process for the preparation of mercury salts of complex bismuthic acids. | |
| AT101337B (en) | Process for the preparation of a basic bismuth salt of guaiacol-o-carboxylic acid. | |
| AT122522B (en) | Process for the preparation of water-soluble complex antimony salts of polyoxymonocarboxylic acids. | |
| AT46292B (en) | Process for the preparation of red to violet basic dyes. | |
| AT103715B (en) | Process for the preparation of therapeutically effective preparations which contain combined glucosides and metals. | |
| AT52837B (en) | Process for the preparation of a new compound of m-cresol with oxalic acid. | |
| AT59697B (en) | Process for the preparation of a new yohimbine salt. | |
| AT123401B (en) | Process for the preparation of 3.3'-dichloro-4.4'-dioxy-5.5'-bisacylaminoarsenobenzenes. | |
| DE552922C (en) | Process for the preparation of a salt of 2,4-diaminoazobenzene | |
| AT157699B (en) | Method for the preparation of water-soluble organic mercury compounds. | |
| AT152663B (en) | Process for the preparation of an agent for disinfecting, wound treatment and the like. like | |
| DE487868C (en) | Manufacture of bleach and disinfectants | |
| DE417973C (en) | Process for the production of colloidal metal solutions | |
| AT79679B (en) | Process for the production of cold liquid glue. | |
| AT243822B (en) | Process for reducing the tendency for sodium chloride to cake | |
| AT119480B (en) | Process for the preparation of addition compounds of sulfur dioxide with aromatic p-diamines. | |
| DE497909C (en) | Process for the preparation of readily soluble salts of N-substituted benzimidazolonarsinic acids | |
| DE944953C (en) | Process for the preparation of a therapeutic agent consisting of the calcium salt of Ca-ethylene diamine tetraacetic acid | |
| AT67784B (en) | Process for the preparation of basic gallocarboxylic acid bismuth. |